Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 20;11(12):3549.
doi: 10.3390/jcm11123549.

Stereotactic Radiotherapy: An Alternative Option for Refractory Ventricular Tachycardia to Drug and Ablation Therapy

Wenfeng Shangguan  1 , Gang Xu  1 , Xin Wang  1 , Nan Zhang  1 , Xingpeng Liu  2 , Guangping Li  1 , Gary Tse  1   3   4 , Tong Liu  1
Affiliations
Review

Stereotactic Radiotherapy: An Alternative Option for Refractory Ventricular Tachycardia to Drug and Ablation Therapy

Wenfeng Shangguan et al. J Clin Med. .

Abstract

Refractory ventricular tachycardia (VT) often occurs in the context of organic heart disease. It is associated with significantly high mortality and morbidity rates. Antiarrhythmic drugs and catheter ablation represent the two main treatment options for refractory VT, but their use can be associated with inadequate therapeutic responses and procedure-related complications. Stereotactic body radiotherapy (SBRT) is extensively applied in the precision treatment of solid tumors, with excellent therapeutic responses. Recently, this highly precise technology has been applied for radioablation of VT, and its early results demonstrate a favorable safety profile. This review presents the potential value of SBRT in refractory VT.

Keywords: refractory ventricular tachycardia; stereotactic body radiotherapy; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Similar articles

See all similar articles

Cited by

References

    1. Bazoukis G., Tse G., Letsas K.P., Thomopoulos C., Naka K.K., Korantzopoulos P., Bazoukis X., Michelongona P., Papadatos S.S., Vlachos K., et al. Impact of ranolazine on ventricular arrhythmias—A systematic review. J. Arrhythmia. 2018;34:124–128. doi: 10.1002/joa3.12031. - DOI - PMC - PubMed
    1. Antiarrhythmics versus Implantable Defibrillators Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N. Engl. J. Med. 1997;337:1576–1583. doi: 10.1056/NEJM199711273372202. - DOI - PubMed
    1. Connolly S.J., Dorian P., Roberts R.S., Gent M., Bailin S., Fain E.S., Thorpe K., Champagne J., Talajic M., Coutu B., et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: The optic study: A randomized trial. JAMA. 2006;295:165–171. doi: 10.1001/jama.295.2.165. - DOI - PubMed
    1. Sapp J.L., Wells G.A., Parkash R., Stevenson W.G., Blier L., Sarrazin J.F., Thibault B., Rivard L., Gula L., Leong-Sit P., et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N. Engl. J. Med. 2016;375:111–121. doi: 10.1056/NEJMoa1513614. - DOI - PubMed
    1. Rivera S., Ricapito M.D., Tomas L., Parodi J., Bardera Molina G., Banega R., Bueti P., Orosco A., Reinoso M., Caro M., et al. Results of cryoenergy and radiofrequency-based catheter ablation for treating ventricular arrhythmias arising from the papillary muscles of the left ventricle, guided by intracardiac echocardiography and image integration. Circ. Arrhythmia Electrophysiol. 2016;9:e003874. doi: 10.1161/CIRCEP.115.003874. - DOI - PubMed

LinkOut - more resources